{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "55eb4b73",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<_duckdb.DuckDBPyConnection at 0x1218fbf30>"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from pathlib import Path\n",
    "import duckdb\n",
    "\n",
    "PROJECT_ROOT = Path.cwd().parent\n",
    "MART_DIR = PROJECT_ROOT / 'data' / 'mart'\n",
    "\n",
    "path_drug_year = MART_DIR / 'mart_drug_year_2026-02-01.parquet'\n",
    "path_prescriber_drug_year = MART_DIR / 'mart_prescriber_drug_year_2026-02-01.parquet'\n",
    "path_prescriber_year = MART_DIR / 'mart_prescriber_year_2026-02-01.parquet'\n",
    "\n",
    "con = duckdb.connect()\n",
    "\n",
    "con.execute(\n",
    "    f\"\"\"\n",
    "    create view mart_drug_year as\n",
    "    select *\n",
    "    from read_parquet('{path_drug_year}')\n",
    "    \"\"\"\n",
    ")\n",
    "\n",
    "con.execute(\n",
    "    f\"\"\"\n",
    "    create view mart_prescriber_drug_year as\n",
    "    select *\n",
    "    from read_parquet('{path_prescriber_drug_year}')\n",
    "    \"\"\"\n",
    ")\n",
    "\n",
    "con.execute(\n",
    "    f\"\"\"\n",
    "    create view mart_prescriber_year as\n",
    "    select *\n",
    "    from read_parquet('{path_prescriber_year}')\n",
    "    \"\"\"\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8a7e1c65",
   "metadata": {},
   "source": [
    "1. Mart: mart_drug_year\n",
    "\n",
    "1.1. Business question\n",
    "- Which drugs account for the largest share of Medicare Part D spending in 2023?\n",
    "\n",
    "1.2. Why this matters\n",
    "- focus price negotiations and rebate strategies on the most impactful drugs;\n",
    "- make informed formulary policy decisions (which drugs to prioritize or restrict)\n",
    "- assess how dependent the overall budget is on a reliatively small set of drugs."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9dbd8644",
   "metadata": {},
   "source": [
    "1.3 Data and grain\n",
    "Forr this analysis, I use:\n",
    "- grain: drug_name, year\n",
    "- filter: year = 2023\n",
    "\n",
    "Rationale for this choice:\n",
    "- the data are already aggregated across all prescribers at the drugs x year level;\n",
    "- there is no unnecessary prescriber_npi dimension, which is not needed for this analysis;\n",
    "- it is convenient to calculate each drug's share of total spending relative to the overall budget.\n",
    "\n",
    "1.4. Metrics\n",
    "Core metrics:\n",
    "- total_drug_cost - total spending on the drug in 2023;\n",
    "- cost_share = total_drug_cost / SUM(total_drug_cost) OVER () - the drug's share of total Part D spending.\n",
    "\n",
    "Optionsl extensions:\n",
    "- cumulative share (e.g., for TOP-N drugs)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "c80a1a7b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>top_10_share</th>\n",
       "      <th>top_50_share</th>\n",
       "      <th>tail_share</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>32.45</td>\n",
       "      <td>60.96</td>\n",
       "      <td>39.04</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   top_10_share  top_50_share  tail_share\n",
       "0         32.45         60.96       39.04"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# -- TOP-10 and TOP-50 of drug spending\n",
    "\n",
    "con.execute(\n",
    "    \"\"\"\n",
    "        with ranked as (\n",
    "            select\n",
    "            generic_name,\n",
    "            total_drug_cost,\n",
    "            row_number() over (order by total_drug_cost desc) as rn\n",
    "            from mart_drug_year\n",
    "            where year = 2023\n",
    "        ),\n",
    "        agg as (\n",
    "            select\n",
    "                sum(total_drug_cost) as total_cost,\n",
    "                sum(case when rn <= 10 then total_drug_cost else 0 end) as top_10_cost,\n",
    "                sum(case when rn <= 50 then total_drug_cost else 0 end) as top_50_cost\n",
    "            from ranked\n",
    "        )\n",
    "        select\n",
    "            round(top_10_cost * 100.0 / total_cost, 2) as top_10_share,\n",
    "            round(top_50_cost * 100.0 / total_cost, 2) as top_50_share,\n",
    "            round((total_cost - top_50_cost) * 100.0 / total_cost, 2) as tail_share\n",
    "        from agg;\n",
    "    \"\"\"\n",
    ").df()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b9c272f0",
   "metadata": {},
   "source": [
    "1.5. Results (Key figures)\n",
    "\n",
    "Based on the mart_drug_year data mart for 2023:\n",
    "- The top 10 drugs by spending account for approximately **32.45%** of the total budget.\n",
    "- The top 50 drugs account for approximately **60.96%** of the total budget.\n",
    "- All remaining drugs (the long tail) account for the remaining **39.04%** of total spending.\n",
    "\n",
    "These results indicate a high concentration of spending in a relatively small set of drugs."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6c1ca217",
   "metadata": {},
   "source": [
    "1.6. Insight\n",
    "\n",
    "Medicare Part D drug spending is highly concentrated, with a limited set of drugs\n",
    "accounting for a substantial share of total expenditures.\n",
    "\n",
    "This follows a classic long-tail pattern:\n",
    "- a small group of drugs (Top 10 / Top 50) generates the majority of spending;\n",
    "- a large number of drugs in the long tail collectively contribute a much smaller\n",
    "  share of the total budget.\n",
    "\n",
    "From a business perspective, this concentration creates clear leverage points:\n",
    "- a small set of drugs should be prioritized for pricing, rebate, and formulary\n",
    "  negotiations;\n",
    "- monitoring price and utilization trends for these drugs can deliver outsized\n",
    "  impact on overall cost control;\n",
    "- effective management of this limited group of high-impact drugs is likely to\n",
    "  yield the greatest budgetary benefits."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5ab4168c",
   "metadata": {},
   "source": [
    "2. Mart: mart_prescriber_drug_year\n",
    "\n",
    "2.1 Business Question\n",
    "- How concentrated are drug expenditures across prescribers,\n",
    "and to what extent do a small number of prescribers drive total drug spending?\n",
    "\n",
    "2.2 Why This Matters\n",
    "Understanding prescriber-level cost concentration is important for:\n",
    "- identifying whether drug spending is driven by a limited number of prescribers\n",
    "- detecting potential outliers or high-impact prescribing patterns\n",
    "- supporting targeted cost-control, compliance, and policy interventions\n",
    "\n",
    "If a small group of prescribers accounts for a disproportionate share of spending,\n",
    "this creates clear leverage points for managing overall program costs."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7812f6ed",
   "metadata": {},
   "source": [
    "2.3. Data and Grain\n",
    "This mart contains aggregated Medicare Part D data for 2023\n",
    "at the **prescriber × drug × year** level.\n",
    "\n",
    "Each row represents total annual metrics for a specific drug\n",
    "prescribed by a specific prescriber.\n",
    "\n",
    "Grain:\n",
    "- prescriber_npi\n",
    "- drug_name\n",
    "- year\n",
    "\n",
    "The grain is fixed: **one row = one prescriber × one drug × one year**.\n",
    "\n",
    "2.4. Metrics\n",
    "- total_drug_cost — total annual cost of prescriptions\n",
    "- total_claims — total number of claims\n",
    "- total_day_supply — total number of days of therapy supplied\n",
    "\n",
    "All metrics are aggregated at the prescriber–drug–year level."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "f4ac993b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>total_cost_billion</th>\n",
       "      <th>top_10_prescriber_pct</th>\n",
       "      <th>top_50_prescriber_pct</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>212.69</td>\n",
       "      <td>3.28</td>\n",
       "      <td>8.6</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   total_cost_billion  top_10_prescriber_pct  top_50_prescriber_pct\n",
       "0              212.69                   3.28                    8.6"
      ]
     },
     "execution_count": 74,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "con.execute(\n",
    "    \"\"\"\n",
    "        with ranked as (\n",
    "            select\n",
    "                generic_name,\n",
    "                npi,\n",
    "                total_drug_cost,\n",
    "                row_number() over (\n",
    "                    partition by generic_name\n",
    "                    order by total_drug_cost desc\n",
    "                ) as rn\n",
    "            from mart_prescriber_drug_year\n",
    "            where year = 2023\n",
    "        ),\n",
    "\n",
    "        agg as (\n",
    "            select\n",
    "                sum(total_drug_cost) as total_cost,\n",
    "                sum(case when rn <= 10 then total_drug_cost else 0 end) as top_10_cost,\n",
    "                sum(case when rn <= 50 then total_drug_cost else 0 end) as top_50_cost\n",
    "            from ranked\n",
    "        )\n",
    "\n",
    "        select\n",
    "            round(total_cost / 1e9, 2) as total_cost_billion,\n",
    "            round(top_10_cost * 100.0 / total_cost, 2) as top_10_prescriber_pct,\n",
    "            round(top_50_cost * 100.0 / total_cost, 2) as top_50_prescriber_pct\n",
    "        from agg;\n",
    "    \"\"\"\n",
    ").df()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a1c15abb",
   "metadata": {},
   "source": [
    "2.5. Results (Key Figures)\n",
    "- Total prescriber–drug expenditures in 2023 amounted to **$216.99 billion**\n",
    "- The top 10 prescribers account for **3.28%** of total drug spending\n",
    "- The top 50 prescribers account for **8.6%** of total drug spending"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "678fc502",
   "metadata": {},
   "source": [
    "2.6. Insight\n",
    "At the system level, drug spending is broadly distributed across prescribers,\n",
    "with no strong evidence of overall prescriber-level concentration.\n",
    "\n",
    "However, within individual drugs, spending is often concentrated among a\n",
    "relatively small number of prescribers. This indicates that prescriber-driven\n",
    "cost concentration is primarily **drug-specific rather than system-wide**.\n",
    "\n",
    "As a result, targeted interventions focused on key prescribers for specific\n",
    "high-impact drugs are likely to be more effective than broad, system-wide\n",
    "prescriber controls."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ea9f6348",
   "metadata": {},
   "source": [
    "3. Mart: mart_drug_year\n",
    "\n",
    "3.1. Business question\n",
    "How concentrated are Medicare Part D expenditures across prescribers overall,\n",
    "and to what extent do a small number of prescribers drive total program spending?\n",
    "\n",
    "3.2. Why this matters\n",
    "Prescriber-level concentration analysis helps:\n",
    "- identify whether overall drug spending is driven by a limited number of prescribers\n",
    "- detect high-impact prescribers contributing disproportionately to total costs\n",
    "- support targeted oversight, compliance, and cost-management initiatives\n",
    "\n",
    "If spending is highly concentrated, system-wide cost control measures may be less effective\n",
    "than focused interventions aimed at a small group of prescribers."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e24a3a7b",
   "metadata": {},
   "source": [
    "3.3 Data and grain\n",
    "This mart contains aggregated Medicare Part D data for 2023\n",
    "at the **prescriber × year** level.\n",
    "\n",
    "Each row represents total annual prescribing metrics\n",
    "for a single prescriber across all drugs.\n",
    "\n",
    "Grain:\n",
    "- prescriber_npi\n",
    "- year\n",
    "\n",
    "The grain is fixed: **one row = one prescriber × one year**.\n",
    "\n",
    "3.4. Metrics\n",
    "- total_drug_cost — total annual cost of all prescriptions written by the prescriber\n",
    "- total_claims — total number of claims across all drugs\n",
    "- total_day_supply — total number of days of therapy supplied\n",
    "\n",
    "All metrics are aggregated at the prescriber-year level."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "id": "3d4df372",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>total_cost_billion</th>\n",
       "      <th>top_10_prescriber_pct</th>\n",
       "      <th>top_50_prescriber_pct</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>212.69</td>\n",
       "      <td>0.39</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   total_cost_billion  top_10_prescriber_pct  top_50_prescriber_pct\n",
       "0              212.69                   0.39                    1.0"
      ]
     },
     "execution_count": 79,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "con.execute(\n",
    "    \"\"\"\n",
    "        with ranked as (\n",
    "            select\n",
    "                npi,\n",
    "                total_drug_cost,\n",
    "                row_number() over (\n",
    "                    order by total_drug_cost desc\n",
    "                ) as rn\n",
    "            from mart_prescriber_year\n",
    "            where year = 2023\n",
    "        ),\n",
    "\n",
    "        agg as (\n",
    "            select\n",
    "                sum(total_drug_cost) as total_cost,\n",
    "                sum(case when rn <= 10 then total_drug_cost else 0 end) as top_10_cost,\n",
    "                sum(case when rn <= 50 then total_drug_cost else 0 end) as top_50_cost\n",
    "            from ranked\n",
    "        )\n",
    "\n",
    "        select\n",
    "            round(total_cost / 1e9, 2) as total_cost_billion,\n",
    "            round(top_10_cost * 100.0 / total_cost, 2) as top_10_prescriber_pct,\n",
    "            round(top_50_cost * 100.0 / total_cost, 2) as top_50_prescriber_pct\n",
    "        from agg;\n",
    "    \"\"\"\n",
    ").df()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "57177e96",
   "metadata": {},
   "source": [
    "3.5. Results (Key Figures)\n",
    "- Total Medicare Part D spending across all prescribers in 2023 amounted to **$212.69 billion**\n",
    "- The top 10 prescribers account for **0.39%** of total spending\n",
    "- The top 50 prescribers account for **1.0%** of total spending"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "81a54caa",
   "metadata": {},
   "source": [
    "3.6. Insight\n",
    "At the system-wide level, Medicare Part D spending is broadly distributed across\n",
    "prescribers, with no evidence of strong prescriber-level concentration.\n",
    "\n",
    "Even the highest-spending prescribers account for only a very small share of total\n",
    "program expenditures, indicating that overall spending is not driven by a limited\n",
    "set of individual prescribers.\n",
    "\n",
    "This suggests that broad, system-wide prescriber controls are unlikely to be\n",
    "effective on their own, and that cost management efforts should instead focus on\n",
    "drug-level drivers and utilization patterns."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c486a6f9",
   "metadata": {},
   "source": [
    "**Cross-Mart Summary: Where Are the Real Cost Drivers?**\n",
    "\n",
    "Across all three marts, different concentration patterns emerge:\n",
    "\n",
    "- At the drug level, spending is highly concentrated among a small number of drugs.\n",
    "- Within individual drugs, expenditures are often driven by a limited number of prescribers.\n",
    "- At the system-wide prescriber level, concentration is relatively low.\n",
    "\n",
    "This indicates that Medicare Part D cost drivers are primarily **drug-specific**\n",
    "rather than **prescriber-wide**.\n",
    "\n",
    "As a result, cost management strategies are likely to be more effective when\n",
    "focused on high-cost drugs and their key prescribers, rather than on broad,\n",
    "system-wide prescriber interventions."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "efd7c0c5",
   "metadata": {},
   "source": [
    "4. Deep dive: top high-cost drugs\n",
    "\n",
    "4.1. Business question\n",
    "What differentiates the highest-cost drugs from the rest of the market,\n",
    "and are high total costs driven primarily by utilization volume\n",
    "or by higher cost per claim?\n",
    "\n",
    "4.2. Why this matters\n",
    "Understanding whether high drug spending is driven by utilization\n",
    "or by cost per claim is critical for effective cost-control strategies.\n",
    "\n",
    "If costs are driven mainly by high utilization, volume management and access controls\n",
    "may be effective. If costs are driven by high cost per claim, pricing,\n",
    "rebate negotiations, and formulary decisions become more important."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "448305dc",
   "metadata": {},
   "source": [
    "4.3 Data and grain\n",
    "This analysis uses the 'mart_drug_year' mart at the **drug × year** grain.\n",
    "Each row represents aggregated annual metrics for a single drug.\n",
    "\n",
    "Grain:\n",
    "- drug_name\n",
    "- year\n",
    "\n",
    "4.4. Metrics\n",
    "- total_drug_cost — total annual drug spending\n",
    "- total_claims — total number of claims\n",
    "- cost_per_claim — average cost per claim (derived metric)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "id": "c7dafe73",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>top5_cost_billion</th>\n",
       "      <th>top5_share_pct</th>\n",
       "      <th>min_cost_per_claim</th>\n",
       "      <th>max_cost_per_claim</th>\n",
       "      <th>min_cost_vs_market</th>\n",
       "      <th>max_cost_vs_market</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>47.27</td>\n",
       "      <td>22.23</td>\n",
       "      <td>862.56</td>\n",
       "      <td>1374.05</td>\n",
       "      <td>16.64</td>\n",
       "      <td>26.5</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   top5_cost_billion  top5_share_pct  min_cost_per_claim  max_cost_per_claim  \\\n",
       "0              47.27           22.23              862.56             1374.05   \n",
       "\n",
       "   min_cost_vs_market  max_cost_vs_market  \n",
       "0               16.64                26.5  "
      ]
     },
     "execution_count": 102,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "con.execute(\n",
    "    \"\"\"\n",
    "        with total as (\n",
    "            select\n",
    "                sum(total_drug_cost) as total_cost\n",
    "            from mart_drug_year\n",
    "            where year = 2023\n",
    "        ),\n",
    "        baseline as (\n",
    "            select\n",
    "                avg(total_drug_cost / nullif(total_claim_count, 0)) as avg_cost_per_claim\n",
    "            from mart_drug_year\n",
    "            where year = 2023\n",
    "        ),\n",
    "        top5_raw AS (\n",
    "            select\n",
    "                generic_name,\n",
    "                total_drug_cost,\n",
    "                total_claim_count\n",
    "            from mart_drug_year\n",
    "            where year = 2023\n",
    "            order by total_drug_cost desc\n",
    "            limit 5\n",
    "        ),\n",
    "        top5_enriched as (\n",
    "            select\n",
    "                t.generic_name,\n",
    "                t.total_drug_cost,\n",
    "                t.total_claim_count,\n",
    "                t.total_drug_cost / nullif(t.total_claim_count, 0) as cost_per_claim,\n",
    "                b.avg_cost_per_claim,\n",
    "                t.total_drug_cost * 100.0 / nullif(t.total_claim_count, 0) / b.avg_cost_per_claim as cost_vs_market_ratio\n",
    "            from top5_raw t\n",
    "            cross join baseline b\n",
    "        )\n",
    "        select\n",
    "            round(sum(total_drug_cost) / 1e9, 2) as top5_cost_billion,\n",
    "            round(sum(total_drug_cost) * 100.0 / any_value(total_cost), 2) as top5_share_pct,\n",
    "            round(min(cost_per_claim), 2) as min_cost_per_claim,\n",
    "            round(max(cost_per_claim), 2) as max_cost_per_claim,\n",
    "            round(min(cost_vs_market_ratio), 2) as min_cost_vs_market,\n",
    "            round(max(cost_vs_market_ratio), 2) as max_cost_vs_market\n",
    "        from top5_enriched, total;\n",
    "    \"\"\"\n",
    ").df()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "89856d3d",
   "metadata": {},
   "source": [
    "4.5. Results (Key Figures)\n",
    "- The top 5 drugs account for **$47.27 billion** in total Medicare Part D spending in 2023.\n",
    "- These drugs represent **22.23%** of total drug spending.\n",
    "- Average cost per claim for the top 5 drugs ranges from **$862.56** to **$1374.05**.\n",
    "- Compared to the market average, cost per claim for these drugs ranges from **16.64% to 26.5% of the market average**.\n",
    "\n",
    "Overall, the top drugs combine a large share of total spending with relatively low\n",
    "cost per claim compared to the broader market."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ec5de88c",
   "metadata": {},
   "source": [
    "4.6. Insight\n",
    "Despite accounting for more than one-fifth of total Medicare Part D spending,\n",
    "the top 5 drugs are not high-cost on a per-claim basis.\n",
    "\n",
    "Their average cost per claim is substantially below the market average,\n",
    "indicating that high total spending is driven primarily by very high utilization\n",
    "rather than elevated prices per prescription.\n",
    "\n",
    "This suggests that cost containment efforts for these drugs may be more effective\n",
    "if focused on utilization management rather than pricing or rebate-based interventions."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "670fa36a",
   "metadata": {},
   "source": [
    "**Executive Summary**\n",
    "\n",
    "This project analyzes Medicare Part D spending patterns for 2023 using a\n",
    "multi-level data mart architecture.\n",
    "\n",
    "The analysis shows that overall spending is highly concentrated at the drug level,\n",
    "while prescriber-level concentration is relatively low at the system level.\n",
    "However, within individual drugs, a small number of prescribers often drive a\n",
    "disproportionate share of costs.\n",
    "\n",
    "In addition, a deep dive into the highest-spending drugs reveals that elevated\n",
    "total costs are primarily driven by very high utilization rather than by high\n",
    "cost per claim.\n",
    "\n",
    "Together, these findings suggest that Medicare Part D cost drivers are largely\n",
    "drug-specific, and that targeted, drug-focused and utilization-based\n",
    "interventions are likely to be more effective than broad, system-wide\n",
    "prescriber controls."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "medicare_part_d (.venv)",
   "language": "python",
   "name": "medicare_part_d"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
